Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,285 | 80,077 | 247,393 | 30,978 | 23,690 |
| Marketable Securities | 175,489 | 184,194 | 137,686 | 86,634 | 42,460 |
| Receivables | 15,529 | 4,017 | 2,975 | 13,835 | 624 |
| Inventories | 9,006 | 6,831 | 3,973 | 1,915 | 4,550 |
| Other current assets | 0 | 0 | 0 | 0 | 1,716 |
| TOTAL | $320,207 | $276,948 | $394,186 | $134,142 | $73,040 |
| Non-Current Assets | |||||
| PPE Net | 80,723 | 76,825 | 39,448 | 36,934 | 36,290 |
| Investments And Advances | 72,792 | 30,975 | 53,304 | 37,025 | 27,430 |
| Other Non-Current Assets | 5,833 | 6,826 | 8,459 | 173 | 210 |
| TOTAL | $159,348 | $114,626 | $101,211 | $74,132 | $63,930 |
| Total Assets | $479,555 | $391,574 | $495,397 | $208,274 | $136,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,933 | 30,309 | 14,830 | 9,446 | 6,550 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,320 |
| TOTAL | $72,923 | $40,118 | $22,022 | $13,786 | $13,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 1,466 | 1,520 |
| Deferred Revenues | 40,173 | 9,659 | 6,766 | 3,728 | N/A |
| aiOther Non-Current Liabilities | 159 | 0 | 0 | 294 | 280 |
| TOTAL | $268,989 | $205,475 | $207,020 | $12,358 | $14,130 |
| Total Liabilities | $341,912 | $245,593 | $229,042 | $26,144 | $27,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,563 | 44,503 | 43,964 | N/A | N/A |
| Common Shares | 55 | 44 | 44 | 37 | 30 |
| Retained earnings | -531,533 | -424,075 | -299,698 | -223,518 | -200,300 |
| Other shareholders' equity | -3,997 | -3,172 | -1,615 | -780 | -490 |
| TOTAL | $137,643 | $145,981 | $266,355 | $182,130 | $109,530 |
| Total Liabilities And Equity | $479,555 | $391,574 | $495,397 | $208,274 | $136,990 |